ANI Pharmaceuticals, Inc. Financial Ratios — ANIP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	-181.2	-84	- -	- -	- -	- -	- -	- -	41.92	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-96.33	-54.81	0.72	18.91	5.64	1.29	-0.29	3.68	1.37	-4.91	-6.91	-6.25	2.26	-1.69	5.75
Return on Capital (%)	- -	- -	-11.17	- -	23.65	8	-1.19	13.72	- -	- -	- -	- -	19.91	- -	16.58
Return on Invested Capital (%)	- -	- -	2.1	- -	9.22	4.66	-0.64	8.05	- -	- -	- -	- -	8.37	- -	6.92
Gross Margin (%)	88.51	100	66.84	79.5	83.37	62.07	55.31	63.77	69.42	58.19	53.45	56.13	62.71	59.27	61.36
EBITDA Margin (%)	-11,668.95	-995.88	6.68	42.67	51.89	38.18	32.32	34.28	29.55	13.94	8.83	10.72	22.46	11.39	19.54
Operating Margin (%)	-11,703.01	-1,007.14	2.99	35.74	42.84	20.81	16.53	17.54	7.95	-7.47	-13.03	-8.13	10.17	0.36	9.2
Incremental Operating Margin (%)	- -	- -	86.64	73.81	62.37	-11.35	5.12	24.77	-380.87	- -	- -	- -	44.16	-37.09	29.37
Pretax Margin (%)	-11,859.66	-1,210.03	0.42	34.62	28.48	6.75	9.24	9.95	1.53	-12.45	-25.94	-19.81	4.08	-3.62	10.84
Profit Margin (%)	-11,859.66	-1,204.73	1	51.36	20.14	3.06	-0.61	7.69	2.95	-10.82	-19.71	-15.14	3.86	-3.01	8.87
Net Income to Common Margin (%)	-11,859.66	-1,204.73	-15.54	51.36	20.14	3.06	-0.61	7.69	2.95	-10.82	-19.8	-15.65	3.52	-3.28	8.74
Effective Tax Rate (%)	- -	- -	15.87	- -	29.26	54.67	106.58	22.73	- -	- -	- -	- -	5.5	- -	18.22
Dvd Payout Ratio (%)	- -	- -	102.18	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-181.2	-84	- -	- -	- -	- -	- -	- -	41.92	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	17	8	- -	107	113	121	202	183	186	186	287	287	286	624	617
ST Debt	- -	8	- -	- -	- -	- -	3	116	10	13	1	1	1	9	17
LT Debt	17	- -	- -	107	113	121	198	67	176	172	287	286	285	615	600
Total Debt/EBITDA	-0.34	-0.34	- -	4.46	2.86	2.46	3.53	2.65	3.04	6.39	15.06	8.45	2.61	8.92	3.57
Net Debt/EBITDA	0.79	1.17	-5.53	-2.62	-1.04	1.9	2.98	2.03	2.02	6.12	9.8	7.03	0.59	6.85	1.92
Total Debt/EBIT	-0.34	-0.34	- -	5.33	3.47	4.51	6.89	5.18	11.31	-11.93	-10.2	-11.13	5.77	281.38	7.6
Net Debt/EBIT	0.78	1.16	-12.37	-3.12	-1.26	3.49	5.83	3.96	7.51	-11.42	-6.64	-9.26	1.3	216.06	4.08
EBITDA to Interest Expense	-74.5	-65.84	4.3	30.35	3.6	4.34	4.75	4.68	4.71	3.08	1.6	1.21	4.06	3.97	8.61
EBITDA-CapEx/Interest Expense	-75.56	-67.59	3.89	-15.08	0.63	-8.82	-4.22	3.94	2.58	-4.15	-0.38	0.62	3.37	3.01	6.9
EBIT to Interest Expense	-74.72	-66.58	1.92	25.42	2.97	2.36	2.43	2.4	1.27	-1.65	-2.36	-0.92	1.84	0.13	4.05
Interest Expense	1	- -	- -	1	11	11	12	15	13	9	12	28	27	18	20
Common Equity/Total Assets	60.62	72.68	-108.92	-7.6	-1.52	-0.9	-0.97	2.67	3.85	-1.08	-6.19	-12.8	-8.86	-7.81	-1.6
Long-Term Debt/Equity (%)	45.85	- -	- -	76.22	70.86	71.11	113.39	34.11	82.62	88.12	79.87	84.38	62.24	143.5	110.92
Long-Term Debt/Capital (%)	31.43	- -	- -	122.72	103.99	102.48	100.33	34.6	86.46	95.42	108.34	133.44	123.63	112.08	100.98
Long-Term Debt/Total Assets (%)	27.79	- -	- -	41.05	39.76	37.37	48.08	15.63	38.49	37.39	37.13	37.58	31.49	47.87	41.64
Total Debt/Equity (%)	45.85	27.98	- -	76.22	70.86	71.11	115.31	92.78	87.29	94.88	80.11	84.63	62.43	145.64	114.11
Total Debt/Capital (%)	31.43	21.86	- -	122.72	103.99	102.48	102.03	94.09	91.35	102.75	108.66	133.83	123.99	113.75	103.89
Total Debt/Total Assets (%)	27.79	20.34	- -	41.05	39.76	37.37	48.89	42.5	40.66	40.26	37.24	37.7	31.59	48.59	42.84
Net Debt to Equity	-105.48	-95.51	-27.11	-44.71	-25.77	54.98	97.49	70.97	58	90.86	52.15	70.39	14.11	111.83	61.3
Net Debt/Capital (%)	1,924.38	-2,126.57	18.64	76.01	90.46	103.23	102.41	92.42	87.53	102.88	113.96	143.67	696.46	118.68	107.49
EBITDA	-51	-23	2	24	40	49	57	69	61	29	19	34	109	70	173
EBITDA-CapEx	-51	-24	2	-12	7	-100	-51	58	33	-39	-5	17	91	53	138
Operating Income (Loss)	-51	-23	1	20	33	27	29	35	16	-16	-28	-26	50	2	81

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	7.92	3.28	3.14	12.77	13.16	0.86	0.79	0.26	1.01	0.1	1.15	0.49	1.52	0.78	1.06
Current Ratio	8.03	3.32	7.83	14.74	16.38	3.22	3.35	0.92	3.04	2.17	3.68	3.46	3.57	2.72	2.71
Quick Ratio	7.92	3.28	6.68	14.08	15.02	2.29	2.29	0.65	2.18	1.32	2.61	2.15	2.63	1.92	2.07
CFO/Avg Current Liab	-6.21	-2.84	-0.78	2.63	1.38	1.26	1.11	0.66	0.4	0.22	0.04	-0.33	0.97	0.38	0.78
Common Equity/Total Assets	60.62	72.68	-108.92	-7.6	-1.52	-0.9	-0.97	2.67	3.85	-1.08	-6.19	-12.8	-8.86	-7.81	-1.6
Long-Term Debt/Equity (%)	45.85	- -	- -	76.22	70.86	71.11	113.39	34.11	82.62	88.12	79.87	84.38	62.24	143.5	110.92
Long-Term Debt/Capital (%)	31.43	- -	- -	122.72	103.99	102.48	100.33	34.6	86.46	95.42	108.34	133.44	123.63	112.08	100.98
Long-Term Debt/Total Assets (%)	27.79	- -	- -	41.05	39.76	37.37	48.08	15.63	38.49	37.39	37.13	37.58	31.49	47.87	41.64
Total Debt/Equity (%)	45.85	27.98	- -	76.22	70.86	71.11	115.31	92.78	87.29	94.88	80.11	84.63	62.43	145.64	114.11
Total Debt/Capital (%)	31.43	21.86	- -	122.72	103.99	102.48	102.03	94.09	91.35	102.75	108.66	133.83	123.99	113.75	103.89
Total Debt/Total Assets (%)	27.79	20.34	- -	41.05	39.76	37.37	48.89	42.5	40.66	40.26	37.24	37.7	31.59	48.59	42.84
CFO/Total Liabilities	-194.88	-238.66	-155	18.4	13.79	17.93	16.61	28.75	18.7	5.75	0.8	-7.4	26.62	7.48	20.59
CFO/CapEx	-66.49	-41.37	-28.71	0.62	0.53	0.18	0.37	6.15	1.66	0.22	0.14	-1.9	6.43	3.78	5.4
Altman's Z-Score	-5.38	-8.48	17.09	4.54	4.28	4.77	3.98	2.77	3.4	1.75	1.59	1.74	2.81	2.04	2.94

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	4.81	3.76	3.89	3.79	3.38	3.26	3.02	2.48	1.93	2.15	2.97	3.2	3.51
Days Sales Outstanding	- -	- -	75.91	97.2	93.8	96.24	108.03	111.93	121.02	147	189.41	169.57	122.78	114.01	103.88
Inventory Turnover	- -	- -	5.67	2.08	1.21	2.47	2.47	1.87	1.42	1.6	1.41	1.48	1.68	2.02	2.44
Days Inventory Outstanding	- -	- -	64.37	175.55	300.6	148.04	147.58	195.51	256.22	228.17	258.48	245.97	217.73	180.87	149.64
Accounts Payable Turnover	0.01	- -	10.55	7.58	7.86	22.58	25.81	12.11	6.03	7.72	7.1	6.22	5.68	6.7	6.42
Accounts Payable Turnover Days	29,254.36	- -	34.6	48.16	46.41	16.17	14.14	30.13	60.54	47.3	51.41	58.72	64.28	54.49	56.83
Cash Conversion Cycle	-29,254.36	- -	105.69	224.59	347.99	228.11	241.47	277.31	316.71	327.86	396.48	356.81	276.23	240.4	196.69
Inventory to Cash Days	- -	- -	11.54	-78.35	-206.79	-51.8	-39.55	-83.58	-135.2	-81.17	-69.07	-76.4	-94.95	-66.86	-45.76
Inventories	- -	- -	4	8	13	26	38	41	48	61	82	105	111	137	143
Raw Materials	- -	- -	1	5	10	14	22	28	35	42	51	68	62	67	74
Work In Process	- -	- -	- -	- -	- -	- -	1	1	- -	1	1	2	3	2	3
Finished Goods	- -	- -	1	1	2	11	14	11	17	20	32	28	36	58	56
Other Inventory	- -	- -	1	1	1	1	2	3	3	3	5	18	10	10	10

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	49	27	102	617	513	694	744	526	730	347	580	654	993	1,068	1,583
- Cash & Cash Equivalents	57	35	11	169	155	27	31	43	62	8	100	48	221	145	286
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25	25	25	25	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	17	8	- -	107	113	121	202	183	186	186	287	287	286	624	617
Enterprise Value	9	- -	91	554	472	787	915	666	854	525	792	917	1,082	1,566	1,905
Total Capital	55	36	-48	87	109	118	198	195	203	181	264	214	230	549	594
Total Debt/Capital (%)	31.43	21.86	- -	122.72	103.99	102.48	102.03	94.09	91.35	102.75	108.66	133.83	123.99	113.75	103.89
Total Debt / EV	1.86	-53.34	- -	0.19	0.24	0.15	0.22	0.27	0.22	0.35	0.36	0.31	0.26	0.4	0.32
EV/Sales	21.38	- -	3.02	9.91	6.18	6.12	5.17	3.3	4.13	2.52	3.67	2.9	2.22	2.55	2.16
EV/EBITDA	- -	- -	45.18	23.21	11.91	16.03	16	9.63	13.99	18.07	41.52	27.04	9.9	22.38	11.04
EV/EBIT	- -	- -	101.03	27.71	14.43	29.41	31.29	18.83	51.97	- -	- -	- -	21.85	705.89	23.46
EV/Cash Flow to Firm	- -	- -	- -	23.9	18.83	24.14	23.68	8.48	12.08	22.37	63.99	- -	7.49	19.9	9.45
EV/Free Cash Flow to Firm	- -	- -	- -	9.4	8.17	4.33	6.24	7.45	8.69	5.72	22	137.06	6.64	16.37	8.07
Diluted Market Cap	49	27	102	623	522	702	744	530	743	347	580	654	1,003	1,068	1,676
Diluted Enterprise Value	9	- -	91	561	480	795	915	670	866	525	792	917	1,093	1,572	2,007
EV per Share	3.4	- -	17.89	50.68	41.5	68.77	79.2	57.01	72.09	43.9	62.9	56.41	60.11	81.05	95.01
TTM Sales	- -	2	30	56	76	129	177	202	207	208	216	316	487	614	883
TTM EBITDA	-51	-23	2	24	40	49	57	69	61	29	19	34	109	70	173
TTM Operating Income	-51	-23	1	20	33	27	29	35	16	-16	-28	-26	50	2	81
TTM Cash Flow to Firm	-47	-25	-5	23	25	33	39	78	71	23	12	-10	144	79	202
TTM Free Cash Flow to Firm	-46	-24	-5	59	58	182	147	89	98	92	36	7	163	96	236

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-1.04	-1.08	-19.24	10.79	10.44	3.97	5.05	6.8	10.15	4.16	21.53	-44.35	7.3	13.19	7.63
EV/EBIT	- -	- -	101.03	27.71	14.43	29.41	31.29	18.83	51.97	- -	- -	- -	21.85	705.89	23.46
Enterprise Value	9	- -	91	554	472	787	915	666	854	525	792	917	1,082	1,566	1,905
Low Price	13.68	6.48	4.8	18.52	36.15	26.8	42.23	36.92	44.4	23.55	26.1	22.31	36.54	52.5	52.74
EV/Sales	21.38	- -	3.02	9.91	6.18	6.12	5.17	3.3	4.13	2.52	3.67	2.9	2.22	2.55	2.16
EV/EBITDA	- -	- -	45.18	23.21	11.91	16.03	16	9.63	13.99	18.07	41.52	27.04	9.9	22.38	11.04
Price/Earnings	- -	- -	- -	21.46	33.37	176.36	- -	33.93	119.83	- -	- -	- -	57.86	- -	20.51
Price/Earnings Average	-4.44	-2.01	-9.53	12.59	40.66	150.49	-574.78	45.11	131.83	-19.49	-10.27	-11.32	52.33	-58.41	19.1
Price/Earnings High	-7.66	-5.79	-24.95	23.38	54.38	206.32	-801.64	55.39	168.97	-36.18	-17.73	-15.85	69.14	-67.9	25.85
Price/Earnings Low	-0.72	-0.85	-5.21	7.05	26.73	77.97	-453.19	27.82	86.27	-12.5	-7.68	-7.33	38.34	-50.34	13.7
Price/Book Value	1.3	0.95	-2.1	-31.28	-117.97	-238.01	-185.82	45.76	41.53	-69.89	-12.15	-6.72	-12.39	-10.65	-68.54
Price/Book Value Average	6.06	1.98	-0.92	-18.35	-143.74	-203.1	-154.42	60.84	45.69	-88.42	-9.2	-5.76	-11.2	-11.74	-63.83
Price/Book Value High	10.46	5.7	-2.41	-34.08	-192.26	-278.45	-215.37	74.69	58.56	-164.12	-15.88	-8.07	-14.8	-13.64	-86.39
Price/Book Value Low	0.99	0.83	-0.5	-10.27	-94.51	-105.22	-121.76	37.52	29.9	-56.68	-6.88	-3.73	-8.21	-10.11	-45.79
Price/Tangible Book Value	1.3	0.95	3.55	6.43	5.59	-86.92	-13.09	-66.37	25.34	96.27	48.86	19.33	5.08	-5.39	-1,234.78
Price/Tangible Book Value Average	6.06	1.98	1.55	3.77	6.81	-74.17	-10.87	-88.24	27.87	121.79	36.99	16.58	4.59	-5.94	-1,150.02
Price/Tangible Book Value High	10.46	5.7	4.06	7.01	9.1	-101.69	-15.17	-108.34	35.72	226.05	63.86	23.19	6.07	-6.9	-1,556.38
Price/Tangible Book Value Low	0.99	0.83	0.85	2.11	4.48	-38.43	-8.57	-54.43	18.24	78.07	27.67	10.72	3.36	-5.12	-824.96
Price/Sales	113.05	11.63	3.38	11.02	6.72	5.39	4.21	2.61	3.54	1.67	2.69	2.07	2.04	1.74	1.79
Price/Sales Average	526.77	24.21	1.48	6.46	8.19	4.6	3.5	3.47	3.89	2.11	2.03	1.77	1.84	1.92	1.67
Price/Sales High	908.89	69.79	3.88	12.01	10.96	6.31	4.88	4.26	4.99	3.91	3.51	2.48	2.44	2.23	2.26
Price/Sales Low	85.91	10.21	0.81	3.62	5.39	2.38	2.76	2.14	2.55	1.35	1.52	1.15	1.35	1.65	1.2
Price/Cash Flow	-1.03	-1.06	-18.57	28	29.72	25.25	18.88	7.84	16	22.76	174.72	-20.96	8.34	16.68	8.55
Price/Cash Flow Average	-4.79	-2.2	-8.12	16.42	36.21	21.55	15.69	10.42	17.61	28.79	132.3	-17.97	7.55	18.38	7.96
Price/Cash Flow High	-8.26	-6.35	-21.27	30.5	48.43	29.55	21.88	12.79	22.57	53.44	228.36	-25.15	9.97	21.37	10.77
Price/Cash Flow Low	-0.78	-0.93	-4.44	9.2	23.81	11.17	12.37	6.43	11.52	18.45	98.96	-11.63	5.53	15.84	5.71
Price/Free Cash Flow Average	-4.86	-2.26	-8.42	6.33	12.72	3.39	4.2	9.04	11.16	5.26	16.3	-38.03	6.6	14.53	7.11
Price/Free Cash Flow High	-8.39	-6.51	-22.04	11.75	17.02	4.65	5.85	11.09	14.31	9.76	28.14	-53.21	8.72	16.89	9.62
Price/Free Cash Flow Low	-0.79	-0.95	-4.6	3.54	8.36	1.76	3.31	5.57	7.3	3.37	12.19	-24.6	4.84	12.53	5.1
EV/Sales Average	435.1	12.52	1.11	5.35	7.65	5.33	4.46	4.16	4.49	2.96	3.01	2.6	2.03	2.74	2.04
EV/Sales High	817.22	58.1	3.51	10.89	10.41	7.04	5.84	4.95	5.58	4.77	4.49	3.31	2.62	3.05	2.63
EV/Sales Low	- -	- -	0.44	2.5	4.84	3.11	3.72	2.83	3.14	2.2	2.5	1.98	1.53	2.47	1.57
EV/EBITDA Average	-3.73	-1.26	16.66	12.53	14.74	13.96	13.8	12.14	15.18	21.24	34.14	24.29	9.03	24.03	10.46
EV/EBITDA High	-7	-5.83	52.55	25.52	20.07	18.43	18.07	14.44	18.89	34.18	50.86	30.89	11.67	26.76	13.48
EV/EBITDA Low	0.05	0.15	6.59	5.87	9.34	8.15	11.51	8.27	10.64	15.81	28.33	18.45	6.83	21.71	8.05
EV/EBIT Average	-3.72	-1.24	37.25	14.96	17.86	25.61	26.99	23.73	56.42	-39.65	-23.13	-32.02	19.93	757.84	22.23
EV/EBIT High	-6.98	-5.77	117.51	30.47	24.31	33.81	35.34	28.23	70.2	-63.82	-34.45	-40.72	25.75	844	28.64
EV/EBIT Low	0.05	0.15	14.74	7	11.31	14.95	22.51	16.15	39.52	-29.52	-19.19	-24.32	15.09	684.52	17.1
Last Price	18	7.38	20.08	56.39	45.12	60.62	64.45	45.02	61.67	29.04	46.08	40.23	55.14	55.28	78.94
High Price	144.72	44.28	23	61.43	73.54	70.92	74.7	73.49	86.96	68.19	60.23	48.26	65.89	70.81	99.5
Enterprise Value Average	189	29	33	299	584	685	789	839	927	617	651	824	987	1,681	1,806
Enterprise Value High	356	134	106	610	795	905	1,033	998	1,153	994	971	1,048	1,275	1,872	2,327
Enterprise Value Low	-3	-3	13	140	370	400	658	571	649	460	541	626	747	1,518	1,389

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	3	4	10	11	11	12	12	12	12	12	17	17	20	21	22
Diluted Weighted Avg Shares	3	4	5	11	12	12	12	12	12	12	13	16	18	19	21
Basic Weighted Avg Shares	3	4	5	11	11	11	12	12	12	12	13	16	18	19	20
Revenue per Share	0.16	0.63	5.93	5.12	6.71	11.24	15.31	17.26	17.44	17.43	17.16	19.46	27.04	31.8	44.05
EBITDA per Share	-18.58	-6.32	0.4	2.18	3.48	4.29	4.95	5.92	5.15	2.43	1.52	2.09	6.07	3.62	8.61
Operating Income per Share	-18.63	-6.39	0.18	1.83	2.88	2.34	2.53	3.03	1.39	-1.3	-2.24	-1.58	2.75	0.11	4.05
Basic EPS, GAAP	-18.88	-7.64	-0.92	2.63	1.35	0.34	-0.09	1.33	0.51	-1.88	-3.4	-3.05	0.95	-1.04	3.85
Basic EPS from Cont Ops	-18.88	-7.64	0.02	2.63	1.35	0.34	-0.09	1.33	0.51	-1.88	-3.38	-2.95	1.04	-0.96	3.91
Diluted EPS, GAAP	-18.88	-7.64	-0.92	2.6	1.33	0.34	-0.09	1.32	0.51	-1.88	-3.4	-3.05	0.94	-1.04	3.64
Diluted EPS from Cont Ops	-18.88	-7.64	0.02	2.6	1.33	0.34	-0.09	1.32	0.51	-1.88	-3.38	-2.95	1.03	-0.96	3.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.1	0.09	0.08	0.06
Cash Flow per Share	-17.52	-6.97	-1.08	2.01	1.52	2.4	3.41	5.74	3.85	1.28	0.26	-1.92	6.61	3.31	9.24
Free Cash Flow per Basic Share	-17.78	-7.14	-1.12	-1.25	-1.36	-10.62	-5.94	4.81	1.53	-4.43	-1.61	-2.93	5.58	2.44	7.53
Cash & Equivalents per Share	20.94	9.59	2.19	15.45	13.6	2.39	2.7	3.68	5.26	0.66	7.96	2.97	12.28	7.83	14.7
Book Value per Share	13.84	7.77	-9.56	-1.8	-0.38	-0.25	-0.35	0.98	1.49	-0.42	-3.79	-5.98	-4.45	-5.19	-1.15
Tangible Book Value per Share	13.84	7.77	5.66	8.76	8.08	-0.7	-4.93	-0.68	2.43	0.3	0.94	2.08	10.86	-10.26	-0.06

ANI Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)